annual shareholders equity:
$710.13M-$30.91M(-4.17%)Summary
- As of today (June 2, 2025), TXG annual stockholders equity is $710.13 million, with the most recent change of -$30.91 million (-4.17%) on December 31, 2024.
- During the last 3 years, TXG annual shareholders equity has fallen by -$107.43 million (-13.14%).
- TXG annual shareholders equity is now -13.14% below its all-time high of $817.57 million, reached on December 31, 2021.
Performance
TXG Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$706.89M-$3.24M(-0.46%)Summary
- As of today (June 2, 2025), TXG quarterly stockholders equity is $706.89 million, with the most recent change of -$3.24 million (-0.46%) on March 31, 2025.
- Over the past year, TXG quarterly shareholders equity has dropped by -$11.94 million (-1.66%).
- TXG quarterly shareholders equity is now -86.17% below its all-time high of $5.11 billion, reached on December 1, 2014.
Performance
TXG quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TXG Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.2% | -1.7% |
| 3 y3 years | -13.1% | -12.4% |
| 5 y5 years | +69.0% | +72.8% |
TXG Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.1% | at low | -12.4% | at low |
| 5 y | 5-year | -13.1% | +69.0% | -14.3% | +80.7% |
| alltime | all time | -13.1% | +422.8% | -86.2% | +421.3% |
TXG Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $706.89M(-0.5%) |
| Dec 2024 | $710.13M(-4.2%) | $710.13M(-1.8%) |
| Sep 2024 | - | $722.80M(-0.2%) |
| Jun 2024 | - | $724.06M(+0.7%) |
| Mar 2024 | - | $718.83M(-3.0%) |
| Dec 2023 | $741.04M(-8.0%) | $741.04M(-0.6%) |
| Sep 2023 | - | $745.22M(-6.1%) |
| Jun 2023 | - | $793.30M(-1.1%) |
| Mar 2023 | - | $802.38M(-0.4%) |
| Dec 2022 | $805.74M(-1.4%) | $805.74M(+3.9%) |
| Sep 2022 | - | $775.79M(-1.0%) |
| Jun 2022 | - | $783.52M(-2.9%) |
| Mar 2022 | - | $806.68M(-1.3%) |
| Dec 2021 | $817.57M(+10.6%) | $817.57M(+2.2%) |
| Sep 2021 | - | $800.22M(+2.0%) |
| Jun 2021 | - | $784.59M(+4.3%) |
| Mar 2021 | - | $752.46M(+1.8%) |
| Dec 2020 | $739.07M | $739.07M(-10.4%) |
| Sep 2020 | - | $825.08M(+110.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $391.27M(-4.4%) |
| Mar 2020 | - | $409.07M(-2.6%) |
| Dec 2019 | $420.08M(-291.0%) | $420.08M(-0.3%) |
| Sep 2019 | - | $421.45M(+2655.3%) |
| Jun 2019 | - | $15.30M(-107.0%) |
| Dec 2018 | -$219.99M(+95.5%) | -$219.99M(-104.5%) |
| Dec 2017 | -$112.51M | - |
| Sep 2017 | - | $4.87B(+2.4%) |
| Jun 2017 | - | $4.76B(+8.5%) |
| Mar 2017 | - | $4.38B(+9.8%) |
| Dec 2016 | - | $3.99B(-6.3%) |
| Sep 2016 | - | $4.26B(+5.4%) |
| Jun 2016 | - | $4.05B(-6.8%) |
| Mar 2016 | - | $4.34B(+5.5%) |
| Dec 2015 | - | $4.11B(-17.8%) |
| Sep 2015 | - | $5.01B(+1.4%) |
| Jun 2015 | - | $4.94B(+0.9%) |
| Mar 2015 | - | $4.90B(-4.2%) |
| Dec 2014 | - | $5.11B |
FAQ
- What is 10x Genomics annual stockholders equity?
- What is the all time high annual shareholders equity for 10x Genomics?
- What is 10x Genomics annual shareholders equity year-on-year change?
- What is 10x Genomics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for 10x Genomics?
- What is 10x Genomics quarterly shareholders equity year-on-year change?
What is 10x Genomics annual stockholders equity?
The current annual shareholders equity of TXG is $710.13M
What is the all time high annual shareholders equity for 10x Genomics?
10x Genomics all-time high annual stockholders equity is $817.57M
What is 10x Genomics annual shareholders equity year-on-year change?
Over the past year, TXG annual stockholders equity has changed by -$30.91M (-4.17%)
What is 10x Genomics quarterly stockholders equity?
The current quarterly shareholders equity of TXG is $706.89M
What is the all time high quarterly shareholders equity for 10x Genomics?
10x Genomics all-time high quarterly stockholders equity is $5.11B
What is 10x Genomics quarterly shareholders equity year-on-year change?
Over the past year, TXG quarterly stockholders equity has changed by -$11.94M (-1.66%)